| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Paradigm Biocapital Advisors LP | 10% | $37,443,949 | 7,429,355 | Paradigm BioCapital Advisors LP | 31 Dec 2024 | |||
| Bain Capital Life Sciences Opportunities IV, L.P. | 10% | 0% | $34,493,528 | -$1,269,203 | 6,843,954 | -3.5% | Bain Capital Life Sciences Opportunities IV, L.P. | 31 Mar 2025 |
| JANUS HENDERSON GROUP PLC | 5.2% | $35,105,462 | 3,585,849 | JANUS HENDERSON GROUP PLC | 30 Sep 2025 | |||
| Deep Track Capital, LP | 5% | $17,351,878 | 3,442,833 | Deep Track Capital, LP | 31 Mar 2025 | |||
| Logos Global Management LP | 4.7% | $16,172,730 | 3,208,875 | Logos Global Management LP | 18 Mar 2025 | |||
| Point72 Asset Management, L.P. | 2.3% | $7,781,412 | 1,543,931 | Point72 Asset Management, L.P. | 31 Mar 2025 |
As of 30 Sep 2025, 123 institutional investors reported holding 68,238,525 shares of Olema Pharmaceuticals, Inc. - Common Stock (OLMA). This represents 99% of the company’s total 68,958,635 outstanding shares.
The largest institutional shareholders of Olema Pharmaceuticals, Inc. - Common Stock (OLMA) together control 88% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 9.9% | 6,843,954 | 0% | 4.4% | $67,002,310 |
| Paradigm Biocapital Advisors LP | 9.9% | 6,794,172 | +0.44% | 2% | $66,514,944 |
| BVF INC/IL | 7.7% | 5,295,893 | 0% | 2.1% | $51,846,792 |
| BlackRock, Inc. | 6.9% | 4,726,394 | +2.6% | 0% | $46,271,397 |
| JANUS HENDERSON GROUP PLC | 5.2% | 3,585,849 | +19% | 0.02% | $35,087,532 |
| Deep Track Capital, LP | 5% | 3,470,172 | +0.79% | 0.95% | $33,972,984 |
| Logos Global Management LP | 4.7% | 3,208,875 | 0% | 3.1% | $31,414,886 |
| VANGUARD GROUP INC | 4.6% | 3,197,320 | -2.1% | 0% | $31,301,763 |
| FRANKLIN RESOURCES INC | 4.4% | 3,011,969 | 0% | 0.01% | $29,487,177 |
| Woodline Partners LP | 3.2% | 2,217,893 | -37% | 0.1% | $21,713,172 |
| LIGHTSPEED MANAGEMENT COMPANY, L.L.C. | 2.8% | 1,930,894 | 0% | 5.9% | $18,903,452 |
| Pictet Asset Management Holding SA | 2.4% | 1,636,372 | -13% | 0.02% | $16,020,082 |
| MORGAN STANLEY | 2.3% | 1,555,887 | +8.2% | 0% | $15,232,135 |
| Vivo Capital, LLC | 2.2% | 1,505,862 | 0% | 1.2% | $14,742,389 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.9% | 1,276,005 | -3.8% | 0% | $12,494,439 |
| Candriam S.C.A. | 1.8% | 1,249,727 | +47% | 0.06% | $12,234,827 |
| CITADEL ADVISORS LLC | 1.8% | 1,236,915 | -28% | 0.01% | $12,109,398 |
| UBS Group AG | 1.7% | 1,190,654 | -16% | 0% | $11,656,502 |
| AMERIPRISE FINANCIAL INC | 1.7% | 1,147,068 | -2.2% | 0% | $11,229,794 |
| STATE STREET CORP | 1.6% | 1,093,574 | +4% | 0% | $10,706,089 |
| DIMENSIONAL FUND ADVISORS LP | 1.5% | 1,064,549 | -12% | 0% | $10,420,648 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1.4% | 933,541 | 1.3% | $9,139,366 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1.2% | 854,000 | 1.3% | $8,360,660 | |
| GOLDMAN SACHS GROUP INC | 1.2% | 803,881 | +11% | 0% | $7,869,995 |
| BANK OF AMERICA CORP /DE/ | 1.2% | 802,304 | +0.35% | 0% | $7,854,556 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 567,259 | $14,181,925 | +$7,923,975 | $25.00 | 8 |
| 2025 Q3 | 68,238,525 | $668,035,985 | -$3,229,145 | $9.79 | 123 |
| 2025 Q2 | 70,511,948 | $300,429,144 | +$22,565,282 | $4.26 | 120 |
| 2025 Q1 | 65,888,228 | $247,927,417 | -$30,654,965 | $3.76 | 131 |
| 2024 Q4 | 71,278,859 | $415,382,388 | +$48,509,843 | $5.83 | 154 |
| 2024 Q3 | 58,658,581 | $700,332,942 | +$12,555,131 | $11.94 | 129 |
| 2024 Q2 | 57,896,539 | $626,445,097 | +$18,080,243 | $10.82 | 127 |
| 2024 Q1 | 56,110,675 | $635,162,151 | +$37,635,929 | $11.32 | 125 |
| 2023 Q4 | 51,618,204 | $717,066,039 | +$56,526,765 | $14.03 | 113 |
| 2023 Q3 | 47,322,813 | $584,436,985 | +$135,063,720 | $12.35 | 97 |
| 2023 Q2 | 36,408,086 | $328,764,561 | +$43,216,272 | $9.03 | 86 |
| 2023 Q1 | 33,447,196 | $116,103,891 | +$1,469,913 | $3.47 | 65 |
| 2022 Q4 | 33,334,567 | $81,640,055 | -$481,138 | $2.45 | 66 |
| 2022 Q3 | 33,359,693 | $92,063,140 | -$4,143,577 | $2.76 | 67 |
| 2022 Q2 | 34,202,982 | $139,234,855 | -$8,391,103 | $4.07 | 70 |
| 2022 Q1 | 36,374,849 | $155,206,361 | -$17,958,891 | $4.26 | 86 |
| 2021 Q4 | 38,428,075 | $359,510,482 | -$41,441,250 | $9.36 | 94 |
| 2021 Q3 | 36,741,334 | $1,012,524,920 | -$19,680,898 | $27.56 | 75 |
| 2021 Q2 | 37,428,321 | $1,047,268,923 | +$59,576,299 | $27.98 | 68 |
| 2021 Q1 | 35,240,926 | $1,158,274,244 | -$1,710,105 | $33.18 | 73 |
| 2020 Q4 | 35,073,865 | $1,657,230,008 | +$1,657,206,010 | $48.08 | 56 |